Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

CTi Biopharma Corp (CEPD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
CTi Biopharma historical data, for real-time data please try another search
8.292 +0.000    +0.00%
23/06 - Delayed Data. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US12648L6011 
S/N:  A2DJWX
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 8.196 - 8.300
CTi Biopharma 8.292 +0.000 +0.00%

NASDAQ:CEPD Financials

 
A brief overview of the NASDAQ:CTIC financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of CTI BioPharma over time.

CTI BioPharma Corp. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 13.42 million compared to USD 37.18 million a year ago. Basic loss per share from continuing operations was USD 0.1 compared to USD 0.37 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

CEPD Income Statement

Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022
Total Revenue 24.12 21.08 18.24 12.33
Gross Profit 22.89 19.92 17.09 11.41
Operating Income -9.23 -15.69 -12.62 -18.88
Net Income -13.42 -17.46 -15.7 -22.65

CEPD Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022
Total Assets 112.27 125.92 123.47 134.53
Total Liabilities 137.62 143.5 140.3 139.81
Total Equity -25.35 -17.58 -16.84 -5.27

CEPD Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  -45.58%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -31.1 -15.51 -15.46 -20.24
Cash From Investing Activities 15.26 0.537 -19.6 -54.79
Cash From Financing Activities 9.63 13.34 1.02 44.22
Net Change in Cash -6.21 -1.63 -34.04 -30.81
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CTIC Comments

Write your thoughts about CTI Biopharma Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Robi Zambo
Robi Zambo Jun 03, 2023 3:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https: // app.bpiq.com / catalyst-calendarhttps :// app.bpiq.com / pdufa-calendar
paola bastoni
paola bastoni Feb 25, 2022 11:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Rialzo a tre cifre percentuali da un momento all'altro
Luca Barbara
Luca Barbara Feb 25, 2022 11:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
cosa ti ha indotto a quel commento? cosa ti aspetti ora che hanno approvato il farmaco?
MIKHAIL KUZNETSOV
MIKHAIL KUZNETSOV Jan 31, 2022 5:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This is Ready for a good run, bought for $2 I'm waiting for a run to the north, there are catalysts for the near future, with this breakthrough attempt it can go crazy.
علی حسینی
علی حسینی Nov 18, 2021 2:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Best buy FDT/HOTBITwill jump very soon
Luca Lanzoni
Luca Lanzoni May 27, 2021 11:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Are we going to have a big spike soon or a big pull back?¿
Ziad Marji
Ziad Marji Apr 01, 2021 4:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
take care guys of high price they are going to make offers soonest with 51mlln $ and the price will drop down
Jan 29, 2021 6:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Scrivi i tuoi pensieri su CTi Biopharma Corp
Luca Lanzoni
Luca Lanzoni Jan 29, 2021 6:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Holding long and strong
Luca Lanzoni
Luca Lanzoni Jan 08, 2021 11:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hello Folks, is it possible CTIC outperform above?  Current Price US$3.49 Fair Value US$41.87 Found it on SimplyWall
Duane Goodson
Duane Goodson Jan 05, 2021 2:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
RDGL approval or denial by Jan 16 by the FDA for breakthrough designation for their tumor fighting drug
Duane Goodson
Duane Goodson Jan 04, 2021 11:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
RDGL 0.125 By 1/16/2021 FDA will provide a final decision to grant or deny their request for breakthrough designation.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email